AR035411A1 - USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE - Google Patents
USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITEInfo
- Publication number
- AR035411A1 AR035411A1 ARP010106058A ARP010106058A AR035411A1 AR 035411 A1 AR035411 A1 AR 035411A1 AR P010106058 A ARP010106058 A AR P010106058A AR P010106058 A ARP010106058 A AR P010106058A AR 035411 A1 AR035411 A1 AR 035411A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- manufacturing
- manufacture
- derivative
- graints
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000508 neurotrophic effect Effects 0.000 title abstract 4
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- 239000004744 fabric Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 210000002569 neuron Anatomy 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000005709 nerve cell growth Effects 0.000 abstract 1
- 239000005022 packaging material Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
El uso de un derivado de tacrolimus de fórmula (1) para la fabricación de un agente neurotrófico. El derivado de fórmula (1) posee un nivel alto de actividad neurotrófica y un nivel reducido de actividad inmunosupresora. Composición que comprende al derivado de fórmula (1) y un artículo de fabricación o un kit que comprende un material de envasado dentro del que se incluye el compuesto (1). Métodos para realizar o fabricar un agente neurotrófico que comprende al compuesto (1). Composición que comprende una célula nerviosa tratada con el compuesto (1). Tejido o injerto que comprenden una célula nerviosa tratada con el compuesto de fórmula (1). Composición que comprende una célula, tejido o injerto tratados con el compuesto (1) y al menos un agente promotor del crecimiento de la célula nerviosa.The use of a tacrolimus derivative of formula (1) for the manufacture of a neurotrophic agent. The derivative of formula (1) has a high level of neurotrophic activity and a reduced level of immunosuppressive activity. Composition comprising the derivative of formula (1) and an article of manufacture or a kit comprising a packaging material within which the compound (1) is included. Methods for making or manufacturing a neurotrophic agent comprising the compound (1). Composition comprising a nerve cell treated with the compound (1). Tissue or graft comprising a nerve cell treated with the compound of formula (1). Composition comprising a cell, tissue or graft treated with the compound (1) and at least one nerve cell growth promoting agent.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25850000P | 2000-12-29 | 2000-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035411A1 true AR035411A1 (en) | 2004-05-26 |
Family
ID=22980816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010106058A AR035411A1 (en) | 2000-12-29 | 2001-12-27 | USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1353671A4 (en) |
| JP (1) | JP2004527472A (en) |
| KR (2) | KR20070030331A (en) |
| CN (1) | CN1293877C (en) |
| AR (1) | AR035411A1 (en) |
| AU (1) | AU2002231277B2 (en) |
| BR (1) | BR0116762A (en) |
| CA (1) | CA2433384A1 (en) |
| CZ (1) | CZ20032060A3 (en) |
| HU (1) | HUP0302521A3 (en) |
| IL (1) | IL156664A0 (en) |
| MX (1) | MXPA03005941A (en) |
| NO (1) | NO20032913D0 (en) |
| NZ (1) | NZ527209A (en) |
| PL (1) | PL366301A1 (en) |
| RU (1) | RU2288716C2 (en) |
| WO (1) | WO2002053159A1 (en) |
| ZA (1) | ZA200305806B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| EP1706117A1 (en) * | 2004-01-20 | 2006-10-04 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
| EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| JP2009102226A (en) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | Spinal cord injury treatment |
| BRPI0916232A2 (en) * | 2008-07-23 | 2017-08-29 | Novartis Ag | SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION |
| EP2817009A1 (en) * | 2012-02-23 | 2014-12-31 | INSERM - Institut National de la Santé et de la Recherche Médicale | Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US537663A (en) * | 1895-04-16 | wubstee | ||
| ES2071681T3 (en) * | 1987-12-09 | 1995-07-01 | Fisons Plc | MACROCYCLE COMPOUNDS. |
| GR1001225B (en) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Novel macrocyclic compositions and new application method thereof |
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| US5541193A (en) * | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| US5968921A (en) * | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/en unknown
- 2001-12-31 PL PL01366301A patent/PL366301A1/en not_active Application Discontinuation
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en not_active Ceased
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 CN CNB018228860A patent/CN1293877C/en not_active Expired - Fee Related
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/en not_active Ceased
- 2001-12-31 IL IL15666401A patent/IL156664A0/en unknown
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/en not_active IP Right Cessation
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/en not_active Application Discontinuation
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/en not_active Expired - Fee Related
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/en unknown
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/en unknown
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/en active IP Right Grant
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/en not_active Ceased
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/en not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100794204B1 (en) | 2008-01-14 |
| NO20032913D0 (en) | 2003-06-24 |
| IL156664A0 (en) | 2004-01-04 |
| CZ20032060A3 (en) | 2004-01-14 |
| BR0116762A (en) | 2004-08-10 |
| NZ527209A (en) | 2005-09-30 |
| RU2288716C2 (en) | 2006-12-10 |
| RU2003123493A (en) | 2005-01-20 |
| CA2433384A1 (en) | 2002-07-11 |
| EP1353671A4 (en) | 2004-07-14 |
| AU2002231277B2 (en) | 2006-11-30 |
| HUP0302521A2 (en) | 2003-11-28 |
| CN1293877C (en) | 2007-01-10 |
| WO2002053159A1 (en) | 2002-07-11 |
| ZA200305806B (en) | 2005-01-26 |
| HUP0302521A3 (en) | 2007-03-28 |
| EP1353671A1 (en) | 2003-10-22 |
| JP2004527472A (en) | 2004-09-09 |
| MXPA03005941A (en) | 2005-02-14 |
| PL366301A1 (en) | 2005-01-24 |
| CN1538843A (en) | 2004-10-20 |
| KR20040007431A (en) | 2004-01-24 |
| KR20070030331A (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5700767A2 (en) | TRANSPLANT REJECTION TREATMENT PROCEDURE | |
| DE60112897D1 (en) | STABILIZATION OF IMPLANTABLE BIOPROTHESEE WEAVE | |
| PA8468401A1 (en) | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | |
| ES2104971T3 (en) | AMINO-SUBSTITUTED BENZOYLGUANIDINES WITH ANTIARRHYTHMIC PROPERTIES. | |
| AR031975A1 (en) | ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM | |
| BR0116345A (en) | Smelly Counteracting Compositions | |
| MX2007003093A (en) | Laundry treatment compositions. | |
| ECSP045239A (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
| EP1100870A4 (en) | Improvement of cardiac function by mesenchymal stem cell transplantation | |
| ES2134937T3 (en) | ALKYL-GLUCOSIDE AND ITS USE. | |
| AR035411A1 (en) | USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE | |
| MX9800680A (en) | Synergistic fungicidal composition including a strobilurine analogue compound. | |
| UY28622A1 (en) | QUINOLONA ANTIBACTERIAL AGENTS | |
| TR200101583T2 (en) | Wood preservative formulations. | |
| AR022017A1 (en) | AN AGENT TO TREAT THE DISORDER OF THE FUNCTION OF VISUAL CELLS. THE METHOD OF TREATMENT AND THE USE OF SUCH AGENT FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION | |
| ES2189206T3 (en) | BETA-ALCOXIACRYLATES AGAINST MALARIA. | |
| CA2433596A1 (en) | Compositions for pre-treating shoes and methods and articles employing same | |
| FI913933A0 (en) | GENOMGAOENDE TAECK- OCH TAETNINGSMEDEL BASERADE PAO POLYURETANDISPERSIONER. | |
| CO5040014A1 (en) | FUNGICIDE BLENDS | |
| ES2054933T3 (en) | CYCLOPROPANOCARBOXAMIDS, PROCEDURE FOR THEIR OBTAINING AND USE FOR THE FIGHT AGAINST PESTS. | |
| ES2126304T3 (en) | SUPPORT FOR THE CULTIVATION OF THE MUSHROOMS, WHICH FAVORS THE GROWTH OF THE MYCELIUM AND THE DEVELOPMENT OF THE CARPOPHORES, AS WELL AS THEIR PROCEDURE FOR OBTAINING. | |
| AR034363A1 (en) | COMPOSITIONS AND METHOD OF MANUFACTURING OF IMPROVED PULP. | |
| AU2003210127A1 (en) | Fireproofing agent | |
| BR0017184A (en) | Acyclic monoterpenes as anti-germinating agents for potato tubers | |
| BRPI0509784A (en) | fungicidal mixtures to combat phytopathogenic harmful fungi, agent, process to combat phytopathogenic harmful fungi, seed, and use of compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |